Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

China Cord Blood Q1 Profit Down - Quick Facts

RELATED NEWS
Trade CO now with 
8/22/2012 7:03 PM ET

China Cord Blood Corp.'s (CO: Quote) net income attributable to shareholders for the first quarter of fiscal 2013 fell by 22.3% to RMB31.1 million or $4.9 million from RMB40.0 million in the prior year period. Earnings per ordinary share for the first quarter of fiscal 2013 were RMB0.41 or $0.06.

Revenues jumped 31.9% to RMB115.3 million or $18.2 million in the first quarter of fiscal 2013 from RMB87.5 million in the prior year period, driven mainly by the expansion in new subscriber numbers and, to a less extent, ongoing increases in the accumulated subscriber base.

Click here to receive FREE breaking news email alerts for China Cord Blood Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Analog Devices, Inc. said that its second quarter profit rose slightly from last year, helped mainly by lower income tax expenses even as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations. However, the company forecast third quarter revenue and earnings below analysts' current consensus estimates. While buying interest was relatively subdued, stocks moved modestly higher over the course of the trading day on Tuesday. The strength on the day offset the weakness seen in the previous session, with the Dow and the S&P 500 reaching new record closing highs. The major averages gave back some ground in late-day trading but remained in positive territory. While a recent series of scandals have caused headaches for the White House, the results of a Washington Post-ABC News poll released Tuesday suggest that the news has not had an impact on President Barack Obama's approval rating. The poll showed that 51 percent of Americans approve of the way Obama is handling his job as president compared to 44 percent that disapprove.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.